These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 567750)

  • 1. Striatal dopamine release and contraversive rotation elicited by intranigrally applied muscimol.
    Martin GE; Haubrich DR
    Nature; 1978 Sep; 275(5677):230-1. PubMed ID: 567750
    [No Abstract]   [Full Text] [Related]  

  • 2. Nigral-derived muscimol circling--ipsiversive, contraversive or controversial?
    Starr MS; Kilpatrick IC
    Nature; 1981 Apr; 290(5807):610. PubMed ID: 6261148
    [No Abstract]   [Full Text] [Related]  

  • 3. Response of dopamine neurons in substantia nigra to muscimol.
    MacNeil D; Gower M; Szymanska I
    Brain Res; 1978 Oct; 154(2):401-3. PubMed ID: 688000
    [No Abstract]   [Full Text] [Related]  

  • 4. BehavioraL and biochemical changes caused by muscimol in mice withdrawN from haloperidol administration.
    Kuruvilla A; Fung YK; Uretsky NJ
    Neuropharmacology; 1982 Sep; 21(9):891-7. PubMed ID: 6890637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA.
    Konieczny J; Czarnecka A; Kamińska K; Lenda T; Nowak P
    Behav Brain Res; 2015 Apr; 283():203-14. PubMed ID: 25655509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related changes in striatal dopamine activity following nigral muscimol infusions.
    Moshé SL; Sperber EF; Wurpel JN; Sharpless NS
    Brain Res; 1987 Jan; 428(1):129-32. PubMed ID: 3815107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral differences induced by muscimol selectively injected into pars compacta and pars reticulata of Substantia nigra.
    Arnt J; Scheel-Krüger J
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Dec; 310(1):43-51. PubMed ID: 575196
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of muscimol, a central GABA receptor agonist, on the catalepsy, striatal homovanillic acid increase, and analgesia induced by pilocarpine in rats.
    Naik SR; Kelkar MR; Amladi SR; Sheth UK
    Psychopharmacology (Berl); 1981; 74(4):393-4. PubMed ID: 6794090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABAA-receptor activation in the subthalamic nucleus compensates behavioral asymmetries in the hemiparkinsonian rat.
    Petri D; Pum M; Vesper J; Huston JP; Schnitzler A
    Behav Brain Res; 2013 Sep; 252():58-67. PubMed ID: 23727148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA agonists and potential antagonists related to muscimol.
    Arnt J; Krogsgaard-Larsen P
    Brain Res; 1979 Nov; 177(2):395-400. PubMed ID: 227538
    [No Abstract]   [Full Text] [Related]  

  • 11. Contralateral turning evoked by the intranigral microinjection of muscimol and other GABA agonists.
    Martin GE; Papp NL; Bacino CB
    Brain Res; 1978 Oct; 155(2):297-312. PubMed ID: 567515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
    Konieczny J; Lenda T; Czarnecka A
    Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons.
    Waszczak BL; Eng N; Walters JR
    Brain Res; 1980 Apr; 188(1):185-97. PubMed ID: 7370752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA receptor agonists: relationship between structure and biological activity in vivo and in vitro.
    Krogsgaard-Larsen P; Krogsgaard-Larsen P; Arnt J; Arnt J
    Adv Exp Med Biol; 1979; 123():303-21. PubMed ID: 390994
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioural and biochemical effects of substance P injected into the substantia nigra of the rat.
    James TA; Starr MS
    J Pharm Pharmacol; 1977 Mar; 29(3):181-2. PubMed ID: 15087
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine release in substantia nigra?
    Korf J; Zieleman M; Westerink BH
    Nature; 1976 Mar; 260(5548):257-8. PubMed ID: 1256566
    [No Abstract]   [Full Text] [Related]  

  • 17. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
    Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM
    Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo release of [3H]GABA in cat caudate nucleus and substantia nigra. I. Bilateral changes induced by a unilateral nigral application of muscimol.
    Kemel ML; Gauchy C; Romo R; Glowinski J; Besson MJ
    Brain Res; 1983 Aug; 272(2):331-40. PubMed ID: 6616207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus.
    Scheel-Krüger J; Magelund G; Olianas MC
    Adv Biochem Psychopharmacol; 1981; 30():165-86. PubMed ID: 7036675
    [No Abstract]   [Full Text] [Related]  

  • 20. GABAergic modulation in the substantia nigra of the striatal dopamine release and of the locomotor activity in rats exposed to helium pressure.
    Balon N; Kriem B; Weiss M; Rostain JC
    Brain Res; 2002 Sep; 948(1-2):82-92. PubMed ID: 12383958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.